Teva secures victory in iron overload treatment dispute

17-11-2022

Staff Writer

Teva secures victory in iron overload treatment dispute

Ralf Liebhold / Shutterstock.com

Judge Hacon rules that a skilled team “would have thought it obvious” to reformulate drug into a tablet | Teva DFX patents also found not to infringe, falling outside the claims on both a normal construction and under the doctrine of equivalents.


Teva, Novartis, patent infringement, English High Court, patents, Teva DFX, deferasirox

LSIPR